IBM and Siemens Healthineers on Tuesday announced that they have formed a strategic alliance in population health management (PHM) aimed at helping various healthcare providers "deliver value-based care to patients with complex, chronic and costly conditions, such as heart disease and cancer."The companies noted that as part of the five-year global partnership, whose financial terms were not disclosed, Siemens Healthineers will offer PHM solutions and services from IBM Watson Health  that are "designed to help meet hospital and healthcare systems' demands for value-based care analytics and reporting, and patient engagement."
Matthias Platsch, head of services at Siemens Healthineers, said "we will bring the power of [our]extensive relationships with providers and our deep domain expertise in clinical workflows, services and digital health technologies to bear to help bring PHM offerings to healthcare providers." He noted that the partnership marks the entry of Siemens Healthineers into the "rapidly growing PHM market,which is expected to play a significant role in end-to-end value-based healthcare."
The companies also indicated plans to eventually "jointly develop and deploy new PHM offerings leveraging each [of their] expertise and assets," including those added to Watson Health's portfolio via acquisitions such as Phytel and Explorys.
"Mature and developing markets are increasingly focused on how patient outcomes are optimised, quality is standardised among individuals and across populations, and costs are reduced," explained IBM Watson Health general manager Deborah DiSanzo. She added that "Siemens and IBM are ideal partners to work at the forefront of this evolution and enable personalised healthcare in the US and globally."